Grazyna Piekos-Sobczak
Pediatric Endocrinology · Phoenix, AZNPI 1992797906
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.1%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Ascendis Pharma Endocrinology Inc accounts for 68.1% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2023 at $8,319 and has fallen 91.1% since, to $740 in 2025. Among pediatric endocrinology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $117.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascendis Pharma Endocrinology Inc$8K
- Pfizer$2K
- BETA Bionics, Inc.$561
- AbbVie$198
- Rhythm Pharmaceuticals, Inc.$191
- Insulet Corporation$169
- plus $1K from 20 others
What the payments were for
- Consulting fees$6,41654%
- Speaking & faculty fees$1,27511%
- Travel & lodging$1,14410%
- Food & beverage$3,01425%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 14 | $8,074 |
| Pfizer | 16 | $1,510 |
| BETA Bionics, Inc. | 4 | $561 |
| AbbVie | 8 | $198 |
| Rhythm Pharmaceuticals, Inc. | 4 | $191 |
| Insulet Corporation | 6 | $169 |
| Novo Nordisk | 10 | $165 |
| Medtronic(2 entities) | 4 | $137 |
| Sequel Med Tech, LLC | 2 | $119 |
| Endo USA, Inc. | 1 | $103 |
| Dexcom, Inc. | 4 | $86 |
| Arbor Pharmaceuticals, Inc. | 4 | $84 |
| Tolmar Pharmaceuticals, Inc. | 3 | $71 |
| Lilly USA, LLC | 4 | $61 |
| Intuity Medical Inc | 2 | $58 |
| Abbott | 3 | $52 |
| Tandem Diabetes Care, Inc. | 3 | $46 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| Tolmar, Inc. | 1 | $21 |
| Zealand Pharma US, Inc. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Amphastar Pharmaceuticals, Inc. | 1 | $16 |
| Companion Medical, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Lifescan, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SKYTROFA$7,768
- iLet Bionic Pancreas$1,684
- NGENLA$1,275
- iLet Insulin Infusion Kit Inset$433
- iLet Insulin Infusion Kit Contact Detach$433
- Imcivree$125
- SUPPRELIN$103
- Omnipod$102
How this compares
$11,849 in reported general payments places this provider in the 90th percentile of 35 pediatric endocrinology providers in Arizona.
Other pediatric endocrinology in Phoenix
- Eileen Baez IrizarryPhoenix$53K
- Pamela SmithPhoenix$26K
- Chirag KapadiaPhoenix$13K
- Rola SaadPhoenix$10K
- Micah OlsonPhoenix$9K
- Rochelle WilsonPhoenix$4K
- Amanda CamposPhoenix$3K
- Mahmoud KabbaniPhoenix$3K
- Melissa ChambersPhoenix$3K
- Dorothee NewbernPhoenix$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.